Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29726936 | 1.00 | IDO1 (0.41) | IDO1TSHRACHEALOX12LMNA | |
| SCHEMBL12817202 | 0.85 | IDO1 (0.34) | IDO1 | |
| SCHEMBL8932025 | 0.85 | ACHE (0.43) | IDO1ACHELMNANPC1RAB9A | |
| SCHEMBL31097920 | 0.83 | SMN1; SMN2 (0.37) | IDO1TSHRACHELMNAMAPT | |
| SCHEMBL987121 | 0.81 | TSHR (0.50) | IDO1TSHRACHEMAPTCYP2A6 | |
| SCHEMBL561045 | 0.81 | IDO1 (0.35) | IDO1 | |
| SCHEMBL13027844 | 0.81 | ALDH1A1 (0.35) | IDO1SMN1; SMN2CYP1A2CA12CA1 | |
| SCHEMBL30676960 | 0.81 | ALDH1A1 (0.35) | IDO1SMN1; SMN2CYP1A2CA12CA1 | |
| SCHEMBL9859144 | 0.78 | IDO1 (0.34) | IDO1 | |
| SCHEMBL560966 | 0.78 | CA1 (0.43) | IDO1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240360549-A1 | LOW-TEMPERATURE DEPOSITION PROCESSES TO FORM MOLYBDENUM-BASED MATERIALS WITH IMPROVED RESISTIVITY | APPLIED MATERIALS, INC. | 2024-10-31 | — | — | US | claimed |
| WO-2024226669-A1 | LOW-TEMPERATURE DEPOSITION PROCESSES TO FORM MOLYBDENUM-BASED MATERIALS WITH IMPROVED RESISTIVITY | APPLIED MATERIALS, INC. (US) | 2024-10-31 | — | — | WO | claimed |
| EP-2794548-A1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | Lucite International UK Limited (GB) | 2014-10-29 | — | — | EP | claimed |
| EP-2007703-B1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INT UK LTD (GB) | 2013-12-18 | — | — | EP | claimed |
| WO-2013093472-A1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INTERNATIONAL UK LIMITED (GB) | 2013-06-27 | — | — | WO | claimed |
| EP-2521616-A1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS, NOVEL CARBONYLATION LIGANDS AND CATALYST SYSTEMS INCORPORATING SUCH LIGANDS | Lucite International UK Limited (GB) | 2012-11-14 | — | — | EP | claimed |
| WO-2011083305-A1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS, NOVEL CARBONYLATION LIGANDS AND CATALYST SYSTEMS INCORPORATING SUCH LIGANDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2011-07-14 | — | — | WO | claimed |
| CN-101553496-A | Novel carbonylation ligands and their use in the carbonylation of ethylenically unsaturated compounds | LUCITE INT UK LTD (GB) | 2009-10-07 | — | — | CN | claimed |
| EP-0251408-A1 | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation | THE PROCTER & GAMBLE COMPANY (US) | 1988-01-07 | — | — | EP | claimed |
| US-12624373-B2 | Process for producing anhydrosugar(s) from lignocellulosic biomass | UNITED ARAB EMIRATES UNIVERSITY (AE) | 2026-05-12 | — | — | US | disclosed |
| US-20260071244-A1 | PROCESS FOR PRODUCING ANHYDROSUGAR(S) FROM LIGNOCELLULOSIC BIOMASS | UNIV UNITED ARAB EMIRATES (AE) | 2026-03-12 | — | — | US | disclosed |
| US-20260041097-A1 | PLANT PRIMING COMPOSITIONS AND METHODS OF USE THEREOF | ZERO GRAVITY SOLUTIONS INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250179349-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-06-05 | — | — | US | disclosed |
| US-12262628-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-03-25 | — | — | US | disclosed |
| EP-0337176-B1 | Novel benzoic acid derivatives and process for preparing the same | SHUDO KOICHI (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5155249-A | Differentiating neoplastic cells, treating psoriasis, immune or inflammatory diseases | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| US-5081271-A | Differentiation-inducing agent for neoplastic cells; therapeutic agent for psoriasis or immune and inflammatory diseases | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0251408-B1 | NOVEL ANTI-INFLAMMATORY AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION | THE PROCTER & GAMBLE COMPANY (US) | 1991-04-17 | — | — | EP | disclosed |
| EP-0337176-A2 | Novel benzoic acid derivatives and process for preparing the same | Shudo, Koichi, Prof. Dr. (JP) | 1989-10-18 | — | — | EP | disclosed |
| EP-0251408-A1 | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation | THE PROCTER & GAMBLE COMPANY (US) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12262628-B2 | Organic electroluminescent materials and devices | OSBP, OCIAD1, OCIAD2 | IDO1 1970/4885TSHR 4153/4885ACHE 881/4885 |
| US-12624373-B2 | Process for producing anhydrosugar(s) from lignocellulosic biomass | AGL, MGAM, UGGT1 | IDO1 1110/4885TSHR 3749/4885ACHE 373/4885 |
| US-20250179349-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OCIAD1, OCIAD2 | IDO1 1970/4885TSHR 4153/4885ACHE 881/4885 |
| US-20260041097-A1 | PLANT PRIMING COMPOSITIONS AND METHODS OF USE THEREOF | XBP1, TFEB, AOC1 | IDO1 849/4885TSHR 3255/4885ACHE 1605/4885 |
| US-20260071244-A1 | PROCESS FOR PRODUCING ANHYDROSUGAR(S) FROM LIGNOCELLULOSIC BIOMASS | AGL, MGAM, UGGT1 | IDO1 1332/4885TSHR 3887/4885ACHE 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.